Evidence map›Paper›PMID 34582313›Full record

ReviewJournal of dual diagnosis

A Narrative Literature Review of the Epidemiology, Etiology, and Treatment of Co-Occurring Panic Disorder and Opioid Use Disorder.

Ashton E Clark, Shelby R Goodwin, Russell M Marks, Annabelle M Belcher, Emily Heinlein, Melanie E Bennett, Daniel J O Roche

Abstract readReview
In one paragraph

Review in Journal of dual diagnosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ashton E ClarkDepartment of Psychiatry, University of Maryland, Baltimore, Maryland, USA.
Shelby R GoodwinDepartment of Psychiatry, University of Maryland, Baltimore, Maryland, USA.
Russell M MarksBaltimore VA Medical Center, Baltimore, Maryland, USA.
Annabelle M BelcherDepartment of Psychiatry, University of Maryland, Baltimore, Maryland, USA.ORCID 0000-0003-4194-0181
Emily HeinleinDepartment of Psychiatry, University of Maryland, Baltimore, Maryland, USA.
Melanie E BennettDepartment of Psychiatry, University of Maryland, Baltimore, Maryland, USA.
Daniel J O RocheDepartment of Psychiatry, University of Maryland, Baltimore, Maryland, USA.ORCID 0000-0001-6298-1519

Funding

Pharmacogenetic Treatment with Anti-Glutaminergic Agents for Comorbid PTSD & AUDR01AA024760 · NIAAA · UNIVERSITY OF MARYLAND BALTIMORE · PI BENNETT, MELANIE E. · 2016 to 2020
$3.0M
Development of minocycline as a neuroimmune therapy for alcohol use disorderK01AA026005 · NIAAA · UNIVERSITY OF MARYLAND BALTIMORE · PI ROCHE, DANIEL · 2017 to 2021
$925k
NIAAA NIH HHS K01 AA026005NIAAA NIH HHS R01 AA024760
6 · The paper itself

Abstract

objectivePanic disorder is a debilitating psychiatric disorder that often co-occurs with substance use disorders. Given the current opioid epidemic, the high reported rates of comorbid panic disorder and opioid use disorder are particularly concerning. In this narrative review, we describe the literature on panic disorder and opioid use disorder co-occurrence.

methods86 studies, 26 reviews, 2 commentaries, and 5 guidelines pertaining to opioid use disorder, panic disorder, and their comorbidity were identified using all EBSCO databases, PubMed, and Google Scholar.

resultsFirst, we review epidemiological literature on the prevalence of the comorbid condition above and beyond each disorder on its own. Additionally, we discuss the challenges that complicate the differential diagnosis of panic disorder and opioid use disorder and contribute to difficulties establishing rates of comorbidity. Second, we review three theoretical models that have been proposed to explain high rates of co-occurring panic disorder and opioid use disorder: the precipitation hypothesis, the self-medication hypothesis, and the shared vulnerability hypothesis. Third, we outline how co-occurring panic and opioid use disorder may impact treatment for each condition.

conclusionBased on findings in the field, we provide recommendations for future research as well as treatment considerations for co-occurring panic and opioid use disorders.

Indexed as

Opioid-Related DisordersPanic DisorderHumansSelf Medicationaddictioncomorbidityexposure therapyOpioid use disorderpanic disordersubstance use disordertreatment

Identifiers

PMID34582313
PMCPMC9487392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.